Lv5
876 积分 2024-08-29 加入
CD19/BAFF-R dual-targeted CAR T cells for the treatment of mixed antigen-negative variants of acute lymphoblastic leukemia
18天前
已完结
In vivo CD19-CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
22天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
30天前
已完结
A humanized monovalent CD3 antibody which can activate homologous complement
1个月前
已完结
Human T lymphocyte activation by monoclonal antibodies; OKT3, but not UCHT1, triggers mitogenesis via an interleukin 2-dependent mechanism
1个月前
已完结
Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAb) with potential usefulness in bispecific mAb generation
1个月前
已完结
Vpx proteins of SIVmac239 and HIV-2ROD interact with the cytoskeletal protein α-actinin 1
4个月前
已完结
Lymphoid tissue chemokines limit priming duration to preserve CD8+ T cell functionality
4个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
5个月前
已完结
Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemias
6个月前
已完结
皖公网安备34019202002308
